CFP
GILD icon

Cornerstone Financial Partners’s Gilead Sciences GILD Stock Holding History

Cornerstone Financial Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-9,557
Closed -$755K – 167
2016
Q3 		$755K Sell
9,557
-1,346
-12% -$109K 0.26% 70
2016
Q2 		$910K Sell
10,903
-25,079
-70% -$2.23M 0.32% 68
2016
Q1 		$3.3M Sell
35,982
-2,111
-6% -$190K 1.28% 19
2015
Q4 		$3.85M Buy
+38,093
New +$3.96M 1.42% 9

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cornerstone Financial Partners's GILD Position: Q4 2016 in Review

Cornerstone Financial Partners sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 9,557 shares — an estimated $755K sold.

Cornerstone Financial Partners first reported a position in GILD in Q4 2015 and held it in 4 quarters. The position peaked at $3.85M in Q4 2015. 1,573 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Cornerstone Financial Partners reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
  • Cornerstone Financial Partners sold 9,557 Gilead Sciences shares in Q4 2016, an estimated $755K.
  • Cornerstone Financial Partners first reported a position in Gilead Sciences in Q4 2015 and held it in 4 quarters.
  • Cornerstone Financial Partners's Gilead Sciences position peaked at $3.85M in Q4 2015.
  • 1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Cornerstone Financial Partners's 13F filing for Q4 2016, filed 10 Feb 2017.